| Item Type | Name |
|
Concept
|
Actinomycetales
|
|
Concept
|
Adenosine Kinase
|
|
Concept
|
Acetates
|
|
Concept
|
Acquired Immunodeficiency Syndrome
|
|
Concept
|
Adenosine
|
|
Concept
|
Adenosine Deaminase
|
|
Concept
|
Antibodies, Bacterial
|
|
Concept
|
Aged, 80 and over
|
|
Concept
|
Attention
|
|
Concept
|
Adenosine Monophosphate
|
|
Concept
|
Agammaglobulinemia
|
|
Concept
|
Aged
|
|
Concept
|
Blood Platelets
|
|
Concept
|
Blood Pressure
|
|
Concept
|
Bordetella pertussis
|
|
Concept
|
Antineoplastic Agents
|
|
Concept
|
Candida
|
|
Concept
|
Cell Communication
|
|
Concept
|
Angiotensin-Converting Enzyme Inhibitors
|
|
Concept
|
Animals
|
|
Concept
|
Antifungal Agents
|
|
Concept
|
Antiviral Agents
|
|
Concept
|
Amphotericin B
|
|
Concept
|
Aspirin
|
|
Concept
|
Biopsy
|
|
Concept
|
Catheterization, Central Venous
|
|
Concept
|
Catalase
|
|
Concept
|
Bordetella Infections
|
|
Concept
|
Coronary Disease
|
|
Concept
|
Cross Infection
|
|
Concept
|
Hepatitis B e Antigens
|
|
Concept
|
Coronary Thrombosis
|
|
Concept
|
Diarrhea
|
|
Concept
|
Dogs
|
|
Concept
|
Edetic Acid
|
|
Concept
|
Eicosanoic Acids
|
|
Concept
|
Galactose
|
|
Concept
|
Hepatitis B Antibodies
|
|
Concept
|
HIV Seropositivity
|
|
Concept
|
Leukemia
|
|
Concept
|
Cross-Sectional Studies
|
|
Concept
|
Double-Blind Method
|
|
Concept
|
Memory, Short-Term
|
|
Concept
|
Infant, Newborn
|
|
Concept
|
Enterocolitis, Pseudomembranous
|
|
Concept
|
Glioblastoma
|
|
Concept
|
Fatty Acids, Unsaturated
|
|
Concept
|
Terminology as Topic
|
|
Concept
|
Histocytochemistry
|
|
Concept
|
DNA, Viral
|
|
Concept
|
Dose-Response Relationship, Drug
|
|
Concept
|
Hydralazine
|
|
Concept
|
Lipoproteins
|
|
Concept
|
Enzyme-Linked Immunosorbent Assay
|
|
Concept
|
Hepatitis B
|
|
Concept
|
Hospitalization
|
|
Concept
|
Flow Cytometry
|
|
Concept
|
Leukoencephalopathy, Progressive Multifocal
|
|
Concept
|
Lipoxygenase
|
|
Concept
|
Luminescent Measurements
|
|
Concept
|
Pilot Projects
|
|
Concept
|
Neutropenia
|
|
Concept
|
Pneumonia, Viral
|
|
Concept
|
Problem Solving
|
|
Concept
|
Opportunistic Infections
|
|
Concept
|
Mycobacterium tuberculosis
|
|
Concept
|
Middle Aged
|
|
Concept
|
Rats, Inbred SHR
|
|
Concept
|
Neutrophils
|
|
Concept
|
Oxygen Inhalation Therapy
|
|
Concept
|
Social Isolation
|
|
Concept
|
Microbial Sensitivity Tests
|
|
Concept
|
Microscopy, Electron
|
|
Concept
|
Platelet Activating Factor
|
|
Concept
|
Pneumococcal Infections
|
|
Concept
|
Oxygen
|
|
Concept
|
Fetal Blood
|
|
Concept
|
Tissue Plasminogen Activator
|
|
Concept
|
Prostatic Neoplasms
|
|
Concept
|
Psychomotor Performance
|
|
Concept
|
Immunoglobulin G
|
|
Concept
|
Recurrence
|
|
Concept
|
Registries
|
|
Concept
|
Risk Factors
|
|
Concept
|
Receptors, Immunologic
|
|
Concept
|
Respiratory Tract Infections
|
|
Concept
|
Cohort Studies
|
|
Concept
|
Mental Recall
|
|
Concept
|
Ribonucleosides
|
|
Concept
|
Serotonin
|
|
Concept
|
DNA-Directed RNA Polymerases
|
|
Concept
|
Hepatitis B Surface Antigens
|
|
Concept
|
Societies, Medical
|
|
Concept
|
Humans
|
|
Concept
|
Immunization
|
|
Concept
|
Incidence
|
|
Concept
|
SRS-A
|
|
Concept
|
Superoxides
|
|
Concept
|
Thromboxane-A Synthase
|
|
Concept
|
United States
|
|
Concept
|
Mycobacterium chelonae
|
|
Concept
|
Kidney
|
|
Concept
|
Urokinase-Type Plasminogen Activator
|
|
Concept
|
Vaccination
|
|
Concept
|
Vaccines, Attenuated
|
|
Concept
|
Hematopoietic Stem Cell Transplantation
|
|
Concept
|
Infectious Disease Transmission, Vertical
|
|
Concept
|
Randomized Controlled Trials as Topic
|
|
Concept
|
Disease Management
|
|
Concept
|
Valine
|
|
Concept
|
5,8,11,14-Eicosatetraynoic Acid
|
|
Concept
|
Vaccines, Inactivated
|
|
Concept
|
Memory Disorders
|
|
Concept
|
Salvage Therapy
|
|
Concept
|
Lymphoma
|
|
Concept
|
Mucor
|
|
Concept
|
Mucorales
|
|
Concept
|
Multiple Myeloma
|
|
Concept
|
Health Behavior
|
|
Concept
|
Leukemia, Myeloid, Acute
|
|
Concept
|
AIDS Dementia Complex
|
|
Concept
|
Bordetella bronchiseptica
|
|
Concept
|
Foscarnet
|
|
Concept
|
Case-Control Studies
|
|
Concept
|
Didanosine
|
|
Concept
|
Age Distribution
|
|
Concept
|
Minocycline
|
|
Concept
|
Treatment Outcome
|
|
Concept
|
Mycobacterium Infections, Nontuberculous
|
|
Concept
|
Peroxidase
|
|
Concept
|
Severe Acute Respiratory Syndrome
|
|
Concept
|
Arachidonic Acid
|
|
Concept
|
Vaccines, Conjugate
|
|
Concept
|
Apoptosis
|
|
Concept
|
Daptomycin
|
|
Concept
|
Respiratory Syncytial Virus Infections
|
|
Concept
|
Enterococcus
|
|
Concept
|
Methicillin-Resistant Staphylococcus aureus
|
|
Concept
|
Patient Isolation
|
|
Concept
|
Nucleic Acid Synthesis Inhibitors
|
|
Concept
|
Plasma
|
|
Concept
|
Pregnancy Complications, Infectious
|
|
Concept
|
Psychiatric Status Rating Scales
|
|
Concept
|
Surveys and Questionnaires
|
|
Concept
|
Severity of Illness Index
|
|
Concept
|
Sulfonamides
|
|
Concept
|
Purinergic P1 Receptor Antagonists
|
|
Concept
|
Rats
|
|
Concept
|
beta-Glucans
|
|
Concept
|
Tubercidin
|
|
Concept
|
Herpes Zoster Vaccine
|
|
Concept
|
HIV Infections
|
|
Concept
|
Multivariate Analysis
|
|
Concept
|
Logistic Models
|
|
Concept
|
Survival Analysis
|
|
Concept
|
Thiazoles
|
|
Concept
|
CD4-CD8 Ratio
|
|
Concept
|
Limit of Detection
|
|
Concept
|
Reproducibility of Results
|
|
Concept
|
Zidovudine
|
|
Concept
|
AIDS-Related Opportunistic Infections
|
|
Concept
|
Treatment Failure
|
|
Concept
|
Myocardial Reperfusion Injury
|
|
Concept
|
Survival Rate
|
|
Concept
|
Coronavirus Infections
|
|
Concept
|
Odds Ratio
|
|
Concept
|
Polymerase Chain Reaction
|
|
Concept
|
Granulocyte Colony-Stimulating Factor
|
|
Concept
|
Fungemia
|
|
Concept
|
Immunoglobulins, Intravenous
|
|
Concept
|
Clinical Trials, Phase III as Topic
|
|
Concept
|
Statistics, Nonparametric
|
|
Concept
|
CD4 Lymphocyte Count
|
|
Concept
|
Hematologic Neoplasms
|
|
Concept
|
Anti-HIV Agents
|
|
Concept
|
Pneumococcal Vaccines
|
|
Concept
|
Coinfection
|
|
Concept
|
Secondary Prevention
|
|
Concept
|
Multiplex Polymerase Chain Reaction
|
|
Concept
|
Pandemics
|
|
Concept
|
Kaplan-Meier Estimate
|
|
Concept
|
Invasive Pulmonary Aspergillosis
|
|
Concept
|
Intention to Treat Analysis
|
|
Concept
|
Anti-Bacterial Agents
|
|
Concept
|
Arachidonic Acids
|
|
Concept
|
Aspergillus
|
|
Concept
|
Canada
|
|
Concept
|
Coronary Vessels
|
|
Concept
|
Disease Models, Animal
|
|
Concept
|
Erythrocytes
|
|
Concept
|
Fibrinolytic Agents
|
|
Concept
|
Graft Occlusion, Vascular
|
|
Concept
|
Health Status
|
|
Concept
|
Hemorrhage
|
|
Concept
|
Kinetics
|
|
Concept
|
Magnetic Resonance Imaging
|
|
Concept
|
Microscopy, Fluorescence
|
|
Concept
|
Mothers
|
|
Concept
|
Prospective Studies
|
|
Concept
|
Reaction Time
|
|
Concept
|
Retrospective Studies
|
|
Concept
|
Theophylline
|
|
Concept
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
|
|
Concept
|
HIV-1
|
|
Concept
|
Zalcitabine
|
|
Concept
|
Disease-Free Survival
|
|
Concept
|
Viral Load
|
|
Concept
|
Rare Diseases
|
|
Concept
|
Gastrointestinal Tract
|
|
Concept
|
Young Adult
|
|
Academic Article
|
Acadesine reduces the frequency of coronary artery reocclusion following rt-PA induced thrombolysis in the dog.
|
|
Academic Article
|
Accelerated neutrophil apoptosis in the acquired immunodeficiency syndrome.
|
|
Academic Article
|
Delayed recognition memory span in HIV-1 infection.
|
|
Academic Article
|
Verbal working memory in HIV-seropositive drug users.
|
|
Academic Article
|
Pseudo-SARS.
|
|
Academic Article
|
Recombinant urokinase for restoration of patency in occluded central venous access devices. A double-blind, placebo-controlled trial.
|
|
Academic Article
|
Posaconazole salvage therapy allows successful allogeneic hematopoietic stem cell transplantation in patients with refractory invasive mold infections.
|
|
Academic Article
|
Successful nonoperative management of gastrointestinal mucormycosis: novel therapy for invasive disease.
|
|
Academic Article
|
Posaconazole as salvage therapy for zygomycosis.
|
|
Academic Article
|
Clinical outcomes, safety, and pharmacokinetics of OPT-80 in a phase 2 trial with patients with Clostridium difficile infection.
|
|
Academic Article
|
Fidaxomicin: first-in-class macrocyclic antibiotic.
|
|
Academic Article
|
Reduced acquisition and overgrowth of vancomycin-resistant enterococci and Candida species in patients treated with fidaxomicin versus vancomycin for Clostridium difficile infection.
|
|
Academic Article
|
Efficacy of fidaxomicin versus vancomycin as therapy for Clostridium difficile infection in individuals taking concomitant antibiotics for other concurrent infections.
|
|
Academic Article
|
Activity of daptomycin with or without 25 percent ethanol compared to combinations of minocycline, EDTA, and 25 percent ethanol against methicillin-resistant Staphylococcus aureus isolates embedded in biofilm.
|
|
Academic Article
|
Renal impairment and clinical outcomes of Clostridium difficile infection in two randomized trials.
|
|
Academic Article
|
Derivation and validation of a simple clinical bedside score (ATLAS) for Clostridium difficile infection which predicts response to therapy.
|
|
Academic Article
|
Emerging therapies for Clostridium difficile infection - focus on fidaxomicin.
|
|
Academic Article
|
Pharmacokinetics of LFF571 and vancomycin in patients with moderate Clostridium difficile infections.
|
|
Academic Article
|
Safety and immunogenicity of heat-treated zoster vaccine (ZVHT) in immunocompromised adults.
|
|
Academic Article
|
Multicenter, randomized clinical trial to compare the safety and efficacy of LFF571 and vancomycin for Clostridium difficile infections.
|
|
Academic Article
|
Histoplasmosis after solid organ transplant.
|
|
Academic Article
|
Neutrophil-platelet interactions and post-ischemic myocardial injury.
|
|
Academic Article
|
Fidaxomicin in Clostridium difficile infection: latest evidence and clinical guidance.
|
|
Academic Article
|
Thromboxane synthase inhibition enhances action of converting enzyme inhibitors.
|
|
Academic Article
|
Herpes zoster and radiation therapy: what radiation oncologists need to know about diagnosing, preventing, and treating herpes zoster.
|
|
Academic Article
|
Activated neutrophils release mediators that may contribute to myocardial injury and dysfunction associated with ischemia and reperfusion.
|
|
Academic Article
|
Safety and Durability of RBX2660 (Microbiota Suspension) for Recurrent Clostridium difficile Infection: Results of the PUNCH CD Study.
|
|
Academic Article
|
Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis.
|
|
Academic Article
|
Acute Myocarditis Secondary to Reactivated Chromosomally-Integrated Human Herpesvirus 6.
|
|
Academic Article
|
Isavuconazole for treatment of rare invasive fungal diseases.
|
|
Academic Article
|
Misdiagnosis of Bordetella bronchiseptica Respiratory Infection as Bordetella pertussis by Multiplex Molecular Assay.
|
|
Academic Article
|
Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease.
|
|
Academic Article
|
Spontaneous chemiluminescence of ETYA (5,8,11,14-eicosatetraynoic acid) is inhibited by catalase or peroxidase.
|
|
Academic Article
|
The Impact of Recurrent Clostridium difficile Infection on Patients' Prevention Behaviors.
|
|
Academic Article
|
Clinical and magnetic resonance imaging regression of progressive multifocal leukoencephalopathy in an AIDS patient after intensive antiretroviral therapy.
|
|
Academic Article
|
Definitions of Resistant and Refractory Cytomegalovirus Infection and Disease in Transplant Recipients for Use in Clinical Trials.
|
|
Academic Article
|
A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant Recipients.
|
|
Academic Article
|
A Phase 2b, Randomized, Double-blind, Placebo-Controlled Multicenter Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of Presatovir in Hematopoietic Cell Transplant Recipients with Respiratory Syncytial Virus Infection of the Lower Respiratory Tract.
|
|
Academic Article
|
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19.
|
|
Academic Article
|
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial.
|
|
Academic Article
|
Needles in a haystack: Extremely rare invasive fungal infections reported in FungiScope?-Global Registry for Emerging Fungal Infections.
|
|
Academic Article
|
Cording in Disseminated Mycobacterium chelonae Infection in an Immunocompromised Patient.
|
|
Academic Article
|
Remdesivir Use in the Setting of Severe Renal Impairment: A Theoretical Concern or Real Risk?
|
|
Academic Article
|
Initial analysis of viral dynamics and circulating viral variants during the mRNA-1273 Phase 3 COVE trial.
|
|
Academic Article
|
American Society for Transplantation and Cellular Therapy Series: #5-Management of Clostridioides difficile Infection in Hematopoietic Cell Transplant Recipients.
|
|
Concept
|
Filgrastim
|
|
Concept
|
Immunogenicity, Vaccine
|
|
Concept
|
Betacoronavirus
|
|
Concept
|
Injection Site Reaction
|
|
Concept
|
Administration, Intravenous
|
|
Concept
|
Patient Acuity
|
|
Concept
|
Microbiota
|
|
Academic Article
|
A Phase 3, Randomized, Double-Blind, Comparator-Controlled Study to Evaluate Safety, Tolerability, and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, in Allogeneic Hematopoietic Cell Transplant Recipients (PNEU-STEM).
|
|
Academic Article
|
MSG-15: Super-Bioavailability Itraconazole Versus Conventional Itraconazole in the Treatment of Endemic Mycoses-A Multicenter, Open-Label, Randomized Comparative Trial.
|